Direct Cortical Stimulation

The key signal is a temporary, site-specific change in function. Brief electrical stimulation can activate or disrupt a local neural network; clinicians then look for reproducible changes in movement, sensation, speech, vision, or cognition. A response at one cortical location indicates that the site participates in the affected function, helping separate eloquent cortex from tissue that may be removable.

Activation and disruption provide complementary information. Activation can provoke activity associated with a function, whereas disruption can temporarily interfere with the network supporting that function. Considering both types of response helps clinicians interpret a cortical site's role rather than relying only on its anatomical position. This matters because surgical decisions depend on functional participation and tissue preservation.

Direct Cortical Stimulation can be performed while the patient is awake or under anesthesia, and the setting affects how functional responses are observed. Awake procedures allow clinicians to assess behaviors such as speech, movement, sensation, vision, and cognition directly. In either setting, stimulation links exposed cortical sites with functional changes relevant to surgical decision-making.

Linking locations to behaviors creates a functional map of human brain organization. This map shows how particular cortical sites relate to movement, sensation, speech, vision, or cognition. Clinically, that relationship guides tissue preservation; scientifically, it advances understanding of how brain functions are organized. The same observations therefore provide both operative guidance and evidence about human cortical specialization.

After the cerebral cortex is exposed, clinicians apply controlled brief currents to relevant sites and observe whether stimulation changes a function. They then link each site with the observed response and use that map to distinguish eloquent cortex from areas considered safer to remove. This workflow supports operative decisions during treatment of brain tumors or drug-resistant epilepsy.

It is particularly relevant when surgeons must remove tissue associated with a brain tumor or drug-resistant epilepsy while limiting injury to functioning cortex. By identifying regions involved in essential behaviors, mapping helps refine the operative target and preserve healthy brain tissue. Its value lies in balancing disease removal against the risk of neurological deficits.

The immediate outcome is a functional map showing which cortical sites correspond to observed changes in movement, sensation, speech, vision, or cognition. That information can support more precise surgical planning and reduce the risk of neurological deficits. It can also reveal relationships between cortical locations and behaviors, contributing to broader clinical knowledge and research on brain organization.